These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2427535

  • 1. Hematologic malignancies: non-Hodgkin's lymphomas.
    DeVita VT.
    Hosp Pract (Off Ed); 1986 Sep 15; 21(9):103-18. PubMed ID: 2427535
    [No Abstract] [Full Text] [Related]

  • 2. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Bron D, Vandenheule B, Stryckmans P.
    Rev Med Brux; 1985 Sep 15; 6(7):491-5. PubMed ID: 2417298
    [No Abstract] [Full Text] [Related]

  • 3. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Björkholm M, Celsing F, Johansson E, Swedish Lymphoma Study Group.
    Ann Hematol; 2006 Oct 15; 85(10):731-3. PubMed ID: 16838163
    [No Abstract] [Full Text] [Related]

  • 4. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST, Miller TP.
    Curr Hematol Rep; 2004 Jan 15; 3(1):17-26. PubMed ID: 14695845
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy for Hodgkin's disease.
    Ekert H.
    N Engl J Med; 2003 Sep 18; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract] [Full Text] [Related]

  • 6. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J.
    Rev Med Brux; 1982 Apr 18; 3(4):223-34. PubMed ID: 6178138
    [No Abstract] [Full Text] [Related]

  • 7. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG, Schoppe WD, Fuchs R, Pflüger KH, Loeffler M, Diehl V.
    Cancer Treat Rep; 1987 Dec 18; 71(12):1203-7. PubMed ID: 2446751
    [Abstract] [Full Text] [Related]

  • 8. ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
    Fisher RI, Young RC, Longo D, DeVita VT.
    Semin Oncol; 1985 Mar 18; 12(1 Suppl 2):29-32. PubMed ID: 2579441
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroid drugs: their role in oncological practice.
    Lowenthal RM, Jestrimski KW.
    Med J Aust; 1986 Jan 20; 144(2):81-5. PubMed ID: 2417096
    [No Abstract] [Full Text] [Related]

  • 10. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 11. [Hematologic tumors].
    Ogawa M.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(10):1416-21. PubMed ID: 14584273
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
    Gaynor ER, Fisher RI.
    Oncology (Williston Park); 1995 Dec 01; 9(12):1273-9; discussion 1283-4. PubMed ID: 8771102
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A, Diehl V, Franklin J, Lohri A, Dörken B, Ludwig WD, Koch P, Hänel M, Pfreundschuh M, Wilhelm M, Trümper L, Aulitzky WE, Bentz M, Rummel M, Sezer O, Müller-Hermelink HK, Hasenclever D, Löffler M.
    J Clin Oncol; 2009 Sep 20; 27(27):4548-54. PubMed ID: 19704068
    [Abstract] [Full Text] [Related]

  • 17. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 20; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 18. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K, Honda T, Hattori M.
    Rinsho Hoshasen; 1983 Jun 20; 28(6):673-7. PubMed ID: 6688641
    [No Abstract] [Full Text] [Related]

  • 19. [Rescue treatment in Hodgkin's disease].
    Zori Comba A, Koziner B.
    Sangre (Barc); 1987 Jun 20; 32(1):67-76. PubMed ID: 2438788
    [No Abstract] [Full Text] [Related]

  • 20. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
    Płuzańska A, Krykowski E, Robak T, Oliskiewicz W, Polkowska E, Dowgier I, Hyjek E.
    Pol Tyg Lek; 1982 Sep 27; 37(36):1049-53. PubMed ID: 6189105
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.